IDH1 and astrocytoma (excluding glioblastoma): For IDH-mutant astrocytomas, the acquisition of CDKN2A/B homozygous deletion corresponds to CNS WHO grade 4, even in the absence of high-grade histological findings (necrosis and microvascular proliferation [MVP]) [3].